Company Filing History:
Years Active: 2006-2013
Title: The Innovative Contributions of Elaine S E Stokes
Introduction
Elaine S E Stokes is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as angiogenesis inhibitors. With a total of two patents to his name, Stokes has demonstrated a commitment to advancing medical science.
Latest Patents
Stokes' latest patents focus on quinazoline derivatives that act as angiogenesis inhibitors. The first patent describes the use of compounds of a specific formula in the manufacture of a medicament aimed at producing an antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals. These compounds inhibit the effects of VEGF, which is crucial in treating various disease states, including cancer and rheumatoid arthritis. The second patent elaborates on similar compounds, detailing their structural components and potential applications in pharmaceutical compositions.
Career Highlights
Stokes is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. His expertise in medicinal chemistry has positioned him as a valuable asset in the quest for innovative treatments.
Collaborations
Stokes has collaborated with several esteemed colleagues, including Darren Mckerrecher and Laurent F A Hennequin. These collaborations have fostered a productive environment for innovation and have led to advancements in their respective fields.
Conclusion
Elaine S E Stokes is a distinguished inventor whose work in developing quinazoline derivatives has the potential to impact the treatment of serious medical conditions. His contributions to AstraZeneca and collaborations with fellow researchers highlight his dedication to innovation in the pharmaceutical industry.